|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF2AK4-MYC (FusionGDB2 ID:25681) |
Fusion Gene Summary for EIF2AK4-MYC |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF2AK4-MYC | Fusion gene ID: 25681 | Hgene | Tgene | Gene symbol | EIF2AK4 | MYC | Gene ID | 440275 | 4609 |
| Gene name | eukaryotic translation initiation factor 2 alpha kinase 4 | MYC proto-oncogene, bHLH transcription factor | |
| Synonyms | GCN2|PVOD2 | MRTL|MYCC|bHLHe39|c-Myc | |
| Cytomap | 15q15.1 | 8q24.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | eIF-2-alpha kinase GCN2GCN2 eIF2alpha kinaseGCN2-like proteingeneral control nonderepressible 2 | myc proto-oncogene proteinavian myelocytomatosis viral oncogene homologclass E basic helix-loop-helix protein 39myc-related translation/localization regulatory factorproto-oncogene c-Myctranscription factor p64v-myc avian myelocytomatosis viral onco | |
| Modification date | 20200313 | 20200329 | |
| UniProtAcc | Q9P2K8 | Q8N699 | |
| Ensembl transtripts involved in fusion gene | ENST00000263791, ENST00000382727, ENST00000559311, ENST00000559624, ENST00000560648, | ENST00000259523, ENST00000377970, ENST00000524013, | |
| Fusion gene scores | * DoF score | 15 X 17 X 10=2550 | 24 X 26 X 9=5616 |
| # samples | 20 | 36 | |
| ** MAII score | log2(20/2550*10)=-3.6724253419715 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(36/5616*10)=-3.96347412397489 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: EIF2AK4 [Title/Abstract] AND MYC [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EIF2AK4(40279494)-MYC(128750838), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | MYC | GO:0000122 | negative regulation of transcription by RNA polymerase II | 9924025|19160485 |
| Tgene | MYC | GO:0006338 | chromatin remodeling | 21533051 |
| Tgene | MYC | GO:0006879 | cellular iron ion homeostasis | 9924025 |
| Tgene | MYC | GO:0006974 | cellular response to DNA damage stimulus | 17873522 |
| Tgene | MYC | GO:0007050 | cell cycle arrest | 10962037 |
| Tgene | MYC | GO:0008284 | positive regulation of cell proliferation | 15994933|19160485 |
| Tgene | MYC | GO:0010332 | response to gamma radiation | 19179467 |
| Tgene | MYC | GO:0010468 | regulation of gene expression | 21447833 |
| Tgene | MYC | GO:0010628 | positive regulation of gene expression | 15459207 |
| Tgene | MYC | GO:0032986 | protein-DNA complex disassembly | 19160485 |
| Tgene | MYC | GO:0035690 | cellular response to drug | 17873522|19179467 |
| Tgene | MYC | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 19179467 |
| Tgene | MYC | GO:0045893 | positive regulation of transcription, DNA-templated | 10962037|17558397|18818310 |
| Tgene | MYC | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10723141 |
| Tgene | MYC | GO:0048146 | positive regulation of fibroblast proliferation | 9924025|18987311 |
| Tgene | MYC | GO:0048147 | negative regulation of fibroblast proliferation | 10962037 |
| Tgene | MYC | GO:0050679 | positive regulation of epithelial cell proliferation | 18987311 |
| Tgene | MYC | GO:0051276 | chromosome organization | 10962037 |
| Tgene | MYC | GO:0051782 | negative regulation of cell division | 10962037 |
| Tgene | MYC | GO:0070371 | ERK1 and ERK2 cascade | 15459207 |
| Tgene | MYC | GO:0071456 | cellular response to hypoxia | 15459207 |
| Tgene | MYC | GO:2001022 | positive regulation of response to DNA damage stimulus | 19179467 |
| Fusion gene breakpoints across EIF2AK4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across MYC (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | H43827 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
Top |
Fusion Gene ORF analysis for EIF2AK4-MYC |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000263791 | ENST00000259523 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000263791 | ENST00000377970 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000263791 | ENST00000524013 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000382727 | ENST00000259523 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000382727 | ENST00000377970 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000382727 | ENST00000524013 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559311 | ENST00000259523 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559311 | ENST00000377970 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559311 | ENST00000524013 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559624 | ENST00000259523 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559624 | ENST00000377970 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000559624 | ENST00000524013 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000560648 | ENST00000259523 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000560648 | ENST00000377970 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| intron-3CDS | ENST00000560648 | ENST00000524013 | EIF2AK4 | chr15 | 40279494 | + | MYC | chr8 | 128750838 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for EIF2AK4-MYC |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EIF2AK4-MYC |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:40279494/:128750838) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EIF2AK4 | MYC |
| FUNCTION: Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to low amino acid availability (PubMed:25329545). Plays a role as an activator of the integrated stress response (ISR) required for adaptation to amino acid starvation (By similarity). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, and thus to a reduced overall utilization of amino acids, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4, and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion (By similarity). Binds uncharged tRNAs (By similarity). Involved in cell cycle arrest by promoting cyclin D1 mRNA translation repression after the unfolded protein response pathway (UPR) activation or cell cycle inhibitor CDKN1A/p21 mRNA translation activation in response to amino acid deprivation (PubMed:26102367). Plays a role in the consolidation of synaptic plasticity, learning as well as formation of long-term memory (By similarity). Plays a role in neurite outgrowth inhibition (By similarity). Plays a proapoptotic role in response to glucose deprivation (By similarity). Promotes global cellular protein synthesis repression in response to UV irradiation independently of the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and p38 MAPK signaling pathways (By similarity). Plays a role in the antiviral response against alphavirus infection; impairs early viral mRNA translation of the incoming genomic virus RNA, thus preventing alphavirus replication (By similarity). {ECO:0000250|UniProtKB:P15442, ECO:0000250|UniProtKB:Q9QZ05, ECO:0000269|PubMed:25329545, ECO:0000269|PubMed:26102367}.; FUNCTION: (Microbial infection) Plays a role in modulating the adaptive immune response to yellow fever virus infection; promotes dendritic cells to initiate autophagy and antigene presentation to both CD4(+) and CD8(+) T-cells under amino acid starvation (PubMed:24310610). {ECO:0000269|PubMed:24310610}. | FUNCTION: May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for EIF2AK4-MYC |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for EIF2AK4-MYC |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF2AK4-MYC |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF2AK4-MYC |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies